Moseley Investment Management Inc. Sells 154 Shares of Procter & Gamble Co (NYSE:PG)

Share on StockTwits

Moseley Investment Management Inc. trimmed its position in shares of Procter & Gamble Co (NYSE:PG) by 1.9% during the 4th quarter, Holdings Channel reports. The firm owned 7,988 shares of the company’s stock after selling 154 shares during the period. Moseley Investment Management Inc.’s holdings in Procter & Gamble were worth $998,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Lucia Wealth Services LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at about $29,000. Belmont Capital LLC purchased a new position in shares of Procter & Gamble during the fourth quarter valued at about $34,000. Selective Wealth Management Inc. purchased a new position in shares of Procter & Gamble during the third quarter valued at about $35,000. Princeton Global Asset Management LLC increased its holdings in shares of Procter & Gamble by 51.4% in the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock worth $48,000 after purchasing an additional 150 shares during the last quarter. Finally, Ironwood Financial llc increased its holdings in shares of Procter & Gamble by 27.3% in the third quarter. Ironwood Financial llc now owns 480 shares of the company’s stock worth $60,000 after purchasing an additional 103 shares during the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

PG opened at $125.96 on Thursday. The stock has a 50-day moving average of $124.20 and a 200 day moving average of $120.41. The company has a current ratio of 0.72, a quick ratio of 0.54 and a debt-to-equity ratio of 0.44. Procter & Gamble Co has a 12 month low of $89.08 and a 12 month high of $126.60. The firm has a market cap of $310.95 billion, a P/E ratio of 27.87, a P/E/G ratio of 3.38 and a beta of 0.40.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.13. The business had revenue of $17.80 billion for the quarter, compared to the consensus estimate of $17.43 billion. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.12 earnings per share. On average, research analysts forecast that Procter & Gamble Co will post 4.94 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $0.7459 per share. This represents a $2.98 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend is Thursday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 65.93%.

In other news, insider Marc S. Pritchard sold 26,075 shares of the firm’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $124.96, for a total value of $3,258,332.00. Following the completion of the sale, the insider now owns 139,066 shares in the company, valued at approximately $17,377,687.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 1,729 shares of Procter & Gamble stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $122.00, for a total transaction of $210,938.00. Following the transaction, the chief executive officer now directly owns 6,856 shares of the company’s stock, valued at $836,432. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,288,513 shares of company stock worth $159,734,252. Corporate insiders own 1.75% of the company’s stock.

A number of research firms recently commented on PG. Macquarie boosted their target price on Procter & Gamble from $132.00 to $138.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 23rd. TheStreet upgraded Procter & Gamble from a “c+” rating to a “b+” rating in a report on Tuesday, October 22nd. Morgan Stanley lifted their price objective on Procter & Gamble from $130.00 to $134.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Goldman Sachs Group reaffirmed a “buy” rating and set a $136.00 price objective on shares of Procter & Gamble in a report on Wednesday, October 23rd. Finally, UBS Group increased their target price on Procter & Gamble from $122.00 to $126.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company’s stock. Procter & Gamble presently has a consensus rating of “Hold” and an average target price of $119.07.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Read More: What is a Call Option?

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.